Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Antigenics Announces Proposed Equity Sale.


Business Editors/Health/Medical Writers

BIOWIRE2K

NEW YORK--(BUSINESS WIRE)--Jan. 26, 2004

Antigenics Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: AGEN) announced today that it plans to publicly offer approximately 5,000,000 shares of its common stock. The offering would be made under the company's existing shelf registration statement.

UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Securities LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 is acting as sole bookrunning manager of this offering, and Needham & Company, Inc. and Ryan Beck & Co., Inc. are acting as co-managers. Antigenics would grant the underwriters an option to purchase an additional 750,000 shares of its common stock within 30 days after the offering to cover over-allotments incurred in the offering.

Antigenics is working to develop personalized immunotherapeutics and revolutionary treatments for cancers, infectious diseases and autoimmune disorders Autoimmune Disorders Definition

Autoimmune disorders are conditions in which a person's immune system attacks the body's own cells, causing tissue destruction.
.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. This offering of the shares of common stock may be made only by means of a prospectus, a copy of which will be available from UBS Securities LLC, 299 Park Avenue, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, NY 10171.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 26, 2004
Words:218
Previous Article:Avid Acquires NXN and Expands Leadership in Digital Asset Management.
Next Article:AmerisourceBergen Reports Operating Margin Expansion and Record Diluted Earnings Per Share for the December Quarter.
Topics:



Related Articles
The who and how of the equity accounting method.
Antigenics Reports Fourth Quarter and Year-End 2002 Results.
Antigenics Reports First Quarter 2003 Financial Results and Recent Highlights.
Antigenics Reports Second Quarter 2003 Financial Results and Recent Highlights.
Antigenics Reports Third Quarter 2003 Financial Results and Recent Highlights.
Antigenics Announces New Appointment and Changes in Senior Management.
Antigenics Prices $52.5 Million Public Offering of Common Stock.
Antigenics Reports Fourth Quarter and Year-End 2003 Financial Results and Highlights.
Antigenics Sells Feline Leukemia Vaccine Manufacturing Business to Virbac S.A. for $14.25 Million in Cash.
Antigenics Reports First Quarter 2004 Financial Results and Recent Highlights.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles